Cardiomo
Remote patient monitoring and wearables platform
Platform · Cloud SaaSCompany source
Company profile
About Cardiomo
Cardiomo is a health technology company specializing in remote patient monitoring and wearable solutions for cardiovascular care. Based on its categorization in the Remote Patient Monitoring & Wearables sector, the company likely develops digital health tools that enable continuous or periodic monitoring of cardiac patients outside traditional clinical settings. The company's name suggests a focus on cardiac monitoring ('Cardio') with a modern, mobile-first approach ('mo'). While specific product details were not available from the limited website content, Cardiomo appears positioned to serve healthcare providers, health systems, and potentially patients directly with technology solutions that facilitate remote cardiac care management. The company operates in the growing digital health market where remote monitoring technologies are increasingly adopted to improve patient outcomes, reduce hospital readmissions, and enable proactive cardiovascular disease management.
Company description Cardiomo official website
Primary marketRemote Patient Monitoring & Wearables
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at Cardiomo?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- cardiac conditions
- cardiovascular disease
Who it serves
- health systems
- providers
Deployment & integration
Cloud Saas deployment with recorded integration context.
Geographic context
MarketsNot currently listed
Company sourceOfficial website
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
No linked records are currently available.
Clinical validation
Clinical-trial records
No linked records are currently available.
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
No Company-reported outcomes are currently listed.
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Updates from Cardiomo
Recent articles published on Cardiomo's official website.
No Company updates are currently listed.
07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Remote Patient Monitoring & Wearables
Companies providing AI-powered remote patient monitoring solutions, wearable health devices with AI analytics, continuous health tracking, or platforms that monitor patients outside clinical settings. Includes general wellness wearables with AI coaching, respiratory monitoring devices, and connected health platforms that aggregate and analyze physiological data from sensors.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.